Harvest & Collection
PRODUCTS
-
The AMP50006 is a high-performance solid state pulse amplifier engineered for demanding X-Band applications requiring high output power, ruggedness, and reliability.
-
Sulfide odor control within sanitary sewers has been practiced for over 50 years, yet only recently have substantive advances been made. Where once the choice of chemical treatment was either chlorine or iron salts, safer and more environmentally benign technologies based on nitrates, hydrogen peroxide, and/or magnesium hydroxide have gained acceptance. These new alternatives, however, can increase treatment costs substantially and present limitations in themselves. Therefore, it makes sense to explore new avenues for lessening the adverse impacts of the older, cheaper mainstays, particularly iron salts (ferrous/ferric chloride or sulfate) that provide other benefits to wastewater treatment operations.
-
Mikart’s development services include a range of pre-formulation capabilities for both oral solid and non-sterile oral liquid dose drug products.
-
Setting a New Benchmark for Ease of Operation
The NP-255 is a robust tablet press that was built to meet even the most demanding needs of the mid-sized tableting industry. The press has features and options designed to increase production, improve tablet quality, reduce waste, and set a new benchmark for ease of operation. Designed, engineered, and manufactured in the USA, this unique machine has a maximum production speed of 192,000 tablets per hour.
With a hardened steel die table, a gravity feeder that is interchangeable with a two-paddle forced feeder, and our industry-leading intuitive Natoli AIM™ ProPluscontrol system, the NP-255 is the new standard for value in the mid-sized tableting industry.
-
Many Life Sciences companies struggle to minimize downtime, ensure safe operations, and reach tight production schedules while maintaining consistent, quality output in a demanding environment, but you can boost efficiency and reliability through our field-tested methodologies.
WHITE PAPERS AND CASE STUDIES
-
Transferring From Microfluidics To A Turbulent Mixer
What solutions did the client featured in this case study find when they sought help in transferring their formulation process to a turbulent Impinged Jet Mixing (IJM)?
-
Cell Line Development For High-Titer Lentivirus Vector Production
Explore a groundbreaking method to significantly enhance LV vector yield using engineered HEK293T cells. This approach paves the way for more efficient and large-scale production of LV vectors.
-
Achieving Excellence In Clinical Research And Quality Management
Lotus Clinical Research, founded in 2001, leverages regulatory expertise and digitalization to enhance quality, automate processes, and improve compliance in biopharmaceutical clinical trials.
-
Relieving The Strain Of Publishing During Regulatory Registration
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
-
Developing A Project Management Office (PMO) At A Small Manufacturing Site
Discover how implementing a Project Management Office transformed a small manufacturing site into a high-performing, strategic asset within a global network.
-
Increasing Productivity On The Production Line With Laser Power Measurement
Dive into how one company's adoption of reliable laser output measurement on its production lines led to increased productivity and cost-efficiency.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Improving Pre-Clinical Study Efficiency With mRNA-LNP Technology
Uncover how Repair Biotechnologies, in collaboration with Vernal Biosciences, helped to pave the way for the next generation of breakthrough treatments for cholesterol and aging-related diseases.
-
FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study
Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
Enhancing Water Quality For Mountaire Farms
Mountaire Farms resolved their wastewater facility issues by replacing mechanical surface aerators with SDOX technology, saving $38 million and improving treatment.
-
A New Story For Myoglobin—Producing Yeast-Generated Alternative
A fast, automated protein analysis workflow empowers researchers to screen yeast strains more efficiently. See how this streamlined approach accelerates innovation while supporting sustainability.
-
Secondary Packaging: Labeling, Cartoning, Clamshell, And Stretch Carding
Tight timelines and coordinated packaging execution drove a high-stakes product launch ahead of a national competitor, ultimately capturing over half the market and setting a new benchmark.
NEWS
-
PulpFixin Announces Strategic Distribution Partnership With Wildcat Laboratory Solutions To Expand Sustainable Lab Products Across The UK And EU4/14/2025
PulpFixin, an innovator of sustainable laboratory products, announced today a new distribution partnership with Wildcat Laboratory Solutions a leading provider of lab equipment and solutions across the United Kingdom and European Union.
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
-
Pocket Alarm Detects And Records RF/Microwave Directed Energy Weapons, Nuclear Events, And Terrestrial Gamma Bursts5/8/2025
Ultraview Corp’s EM/GAMMALERT is a new pocket device that warns of RF/microwave jammer and directed energy weapon deployment1 - an emerging threat speculated as a modality in “Havana Syndrome”.
-
Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer's Drug4/28/2025
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively licensed to Silo Pharma from Columbia University.
-
Consulta Remedios Selects Kevel's Retail Media Cloud To Power Its Next-Generation Advertising Platform5/2/2025
Kevel, the leading provider of API-based retail media ad serving technology, today announced that Consulta Remédios, Brazil's largest medicine price comparison platform, has selected Kevel's Retail Media Cloud to power the development and enhancement of its in-house retail media network.
ABOUT
Harvest and Collection
Harvest and collection is the process used to retrieve biological agents and vaccines present in cell cultures or to harvest and collect stem cells from blood or bone marrow. Many bioresearch companies have sophisticated systems for harvesting and collecting cells. These systems make counting cells easier and they also protect against contamination.
Cells are harvested once the cells reach a density level in the cell culture medium that precludes further growth. The best time to harvest cells is when they are in a confluent state (at least 50% of the culture dish is covered and before 100% of the dish is covered).
Cells can be harvested using on of three methods: Mechanical, using Proteolytic enzymes, or using EDTA. Mechanical harvesting uses a rubber spatula to remove the cells from the growth surface or culture. This method is quick but can cause many cells to die because it is highly disruptive. This method is favored when harvesting lots of different samples of cells to prepare extracts.
In this case, viability of the cells doesn’t matter. Three enzymes; Trypsin, Collagenase, and Pronase can be used in combination with EDTA. The combination of these enzymes with the EDTA makes cells detach from the growth medium.
This method is easy but also has a downside. It can damage the cell surface by eating up exposed cell surface proteins. EDTA can be used alone to detach cells from their medium and it is gentler than using trypsin.
Normally, collected cells are placed in a new suspension, or growth medium to continue growing new cultures. This is referred to as passaging or splitting the cells.